Claude Haan

6, Avenue Du Swing
Belvaux, ES L4367, Luxembourg

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Targeting the energy metabolism of melanoma cells: FX-11 acts as a mitochondrial uncoupler.

Targeting the energy metabolism of melanoma cells: FX-11 acts as a mitochondrial uncoupler.

Journal: European journal of pharmacology

Published: August 01, 2025

CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells.

CCT196969 effectively inhibits growth and survival of melanoma brain metastasis cells.

Journal: PloS one

Published: March 18, 2022

Systematic Transcriptional Profiling of Responses to STAT1- and STAT3-Activating Cytokines in Different Cancer Types.

Systematic Transcriptional Profiling of Responses to STAT1- and STAT3-Activating Cytokines in Different Cancer Types.

Journal: Journal of molecular biology

Published: July 20, 2020

Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3.

Modulation of the IL-6-Signaling Pathway in Liver Cells by miRNAs Targeting gp130, JAK1, and/or STAT3.

Journal: Molecular therapy. Nucleic acids

Published: December 21, 2018

Many ways to resistance: How melanoma cells evade targeted therapies.

Many ways to resistance: How melanoma cells evade targeted therapies.

Journal: Biochimica et biophysica acta. Reviews on cancer

Published: December 04, 2018

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells.

Kinase inhibitor library screening identifies synergistic drug combinations effective in sensitive and resistant melanoma cells.

Journal: Journal of experimental & clinical cancer research : CR

Published: August 29, 2018

A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells.

A new ALK isoform transported by extracellular vesicles confers drug resistance to melanoma cells.

Journal: Molecular cancer

Published: May 14, 2018

The PD-L1- and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by α-PD-L1 or α-IL6 antibodies.

The PD-L1- and IL6-mediated dampening of the IL27/STAT1 anticancer responses are prevented by α-PD-L1 or α-IL6 antibodies.

Journal: Journal of leukocyte biology

Published: January 12, 2018

Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.

Oncostatin M induces RIG-I and MDA5 expression and enhances the double-stranded RNA response in fibroblasts.

Journal: Journal of cellular and molecular medicine

Published: January 18, 2017

Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells.

Phosphorylation of the pyruvate dehydrogenase complex precedes HIF-1-mediated effects and pyruvate dehydrogenase kinase 1 upregulation during the first hours of hypoxic treatment in hepatocellular carcinoma cells.

Journal: Hypoxia (Auckland, N.Z.)

Published: November 02, 2016

The multi-site docking protein Gab1 is constitutively phosphorylated independent from its recruitment to the plasma membrane in Jak2-V617F-positive cells and mediates proliferation of human erythroleukaemia cells.

The multi-site docking protein Gab1 is constitutively phosphorylated independent from its recruitment to the plasma membrane in Jak2-V617F-positive cells and mediates proliferation of human erythroleukaemia cells.

Journal: Cellular signalling

Published: October 06, 2016

ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.

ROS production induced by BRAF inhibitor treatment rewires metabolic processes affecting cell growth of melanoma cells.

Journal: Molecular cancer

Published: September 21, 2016

Showing 1-12 of 24

Last Updated: 09/26/2026